Biomarin Pharmaceutical (BMRN) Gross Margin (2009 - 2026)
Biomarin Pharmaceutical (BMRN) recorded Gross Margin of 79.51% in Q2 2026, down 2.31 percentage points from 81.82% a year earlier but up 4.96 percentage points from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Gross Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Biomarin Pharmaceutical's Gross Margin came in at 76.12% as of Jun 30, 2026, down 3.44 percentage points year-over-year; for FY2025, it came in at 77.73%, down 1.94 percentage points from FY2024.
- Annual Gross Margin has a five-year change of +5.91 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 79.67% in FY2024 (+1.66 pp), 78.01% in FY2023 (+2.01 pp), 76.00% in FY2022 (+1.49 pp) and 74.52% in FY2021 (+2.70 pp).
- Quarterly Gross Margin has ranged from 68.47% in Q4 2025 to 81.95% in Q3 2025 over the past five years.
- On a year-over-year basis, Gross Margin has declined for three consecutive quarters, with an average year-over-year change of -1.82 percentage points over the last eight quarters.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 14.27 percentage points in Q3 2021, against a drop of 13.31 percentage points in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 74.55% (Q1 2026), 68.47% (Q4 2025) and 81.95% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn | 79.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.51% |
| Mar 31, 2026 | 74.55% |
| Dec 31, 2025 | 68.47% |
| Sep 30, 2025 | 81.95% |
| Jun 30, 2025 | 81.82% |
| Mar 31, 2025 | 79.66% |
| Dec 31, 2024 | 81.78% |
| Sep 30, 2024 | 74.73% |
| Jun 30, 2024 | 81.68% |
| Mar 31, 2024 | 80.71% |
| Dec 31, 2023 | 78.66% |
| Sep 30, 2023 | 77.97% |
| Jun 30, 2023 | 78.06% |
| Mar 31, 2023 | 77.29% |
| Dec 31, 2022 | 72.72% |
| Sep 30, 2022 | 76.99% |
| Jun 30, 2022 | 76.93% |
| Mar 31, 2022 | 77.48% |
| Dec 31, 2021 | 73.38% |
| Sep 30, 2021 | 74.67% |
API Access
Biomarin Pharmaceutical Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();